LASP1 and breast carcinoma: Recent studies provided evidence that stable silencing of LASP1 also reduced gene expression levels of MMP9 and 1 in MDA-Bone-Un breast cancer cells (MDA-MB-231 cells that were re-isolated from mouse bone metastatic lesions) (19).